Docetaxel and 5-fluorouracil as first-line treatment for patients with advanced gastric cancer.
Veliparib combined with oral cyclophosphamide showed promising clinical activity in BRCA-mutant solid tumors.
The FDA has approved Imbruvica (ibrutinib) for the treatment of previously treated patients with Waldenström's macroglobulinemia.
Multidisciplinary cancer team meetings need to systematically consider treatment of patients with comorbidity.
Nimotuzumab has shown promising efficacy for high grade glioma.
For mammography, there has been an increase in biopsies with diagnoses of invasive carcinoma and ductal carcinoma in situ (DCIS).
Researchers have identified certain prognostic factors for survival in patients with Ewing's sarcoma.
Neutrophil-lymphocyte ratio (NLR) change is a potential biomarker for survival in advanced pancreatic cancer.
Prostate biopsies that combine magnetic resonance imaging (MRI) technology with ultrasound give men better information.
Many women with breast cancer lack basic knowledge about their disease, such as their cancer stage and other characteristics
Smoking increases risks for side effects and recurrence in patients being treated for prostate cancer.
Capecitabine is not noninferior to approved intermittent capecitabine regimen for the treatment of metastatic breast cancer.
Effect of panitumumab and radiotherapy in unresected locally advanced head and neck squamous cell carcinoma.
Combination bevacizumab with radiotherapy and temozolomide is safe in glioblastoma, but low response rates do not favor a neoadjuvant approach.
The risk for developing a glioma appears to go up with long-term use of hormonal contraceptives.
Health sector prices explain much of difference between U.S. and other high-spending countries.
Millions signing up for Medicaid to comply with federal health care law.
Almost 80% of doctors in the United States have switched from paper to electronic health records.
Most physicians believe that doctors order too many medical tests, yet half admit to doing so themselves in response to a patient who insists, a new survey shows.
Several modifiable risk factors can cut chronic disease deaths over the next 15 years.
Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.
A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.
The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.
ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.
Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.
Sign Up for Free e-newsletters
Cancer Therapy Advisor Articles
- European Society for Medical Oncology (ESMO) Renal Cell Carcinoma Practice Guidelines
- Bevacizumab Plus Temozolomide Produces Low Response in Newly-Diagnosed Glioblastoma
- Abiraterone Acetate Prolongs Survival in Metastatic Prostate Cancer
- Standard-Dose vs. High-Dose Chemoradiotherapy With, Without Cetuximab for Lung Cancer
- Surveillance Until Rituximab Retreatment Does Not Increase Anxiety in Non-Hodgkin Lymphoma
- Current and Emerging Therapies for Bone Metastatic Castration-Resistant Prostate Cancer
- Docetaxel and 5-Fluorouracil: Promising Novel Regimen for Advanced Gastric Cancer
- Addition of Veliparib to Cyclophosphamide Ineffective for Ovarian Cancer
- FDA Approves Imbruvica for Waldenström's Macroglobulinemia
- Multidisciplinary Cancer Teams Lack Information on Patients' Comborbidity
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|